Men<unk><unk>  is the classic treatment of hypogonadism., It is also used in men who have lost the ability to produce<unk> s due to disease or its treatment. Diabetes The risks of diabetes and of testosterone deficiency in men over 45 (i.e., hypogonadism, specifically hypoandrogenism) are strongly correlated. Testosterone<unk>  therapies have been shown to improve blood glucose management. Still, "it is prudent not to start testosterone therapy in men with diabetes solely for the purpose of improving metabolic control if they show no signs and symptoms of hypogonadism." Women<unk><unk>  is used in postmenopausal women: the indications are to increase sexual desire; and to prevent or treat osteoporosis. Other symptoms of<unk>  deficiency are similar in both sexes, such as muscle loss and physical fatigue. The<unk> s used for<unk><unk>  in women include testosterone (and esters), prasterone (dehydroepiandrosterone; DHEA) (and the ester prasterone enanthate), methyltestosterone, nandrolone decanoate, and tibolone, among others.
Androgen replacement therapy
Transgender hormone therapy
Feminizing hormone therapy
Androgen deprivation therapy
Sex reassignment surgery
Sex reassignment surgery 
Hormone replacement therapy
Masculinizing hormone therapy